Literature DB >> 21700737

In vitro assessment of the antifungal and paradoxical activity of different echinocandins against Candida tropicalis biofilms.

Tsun Sheng N Ku1,2, Stella M Bernardo1,2, Samuel A Lee1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21700737      PMCID： PMC7300836          DOI： 10.1099/jmm.0.032235-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN： 0022-2615            Impact factor:   2.472


× No keyword cloud information.
  22 in total

1.  Effects of serum on in vitro susceptibility testing of echinocandins.

Authors:  Zekaver Odabasi; Victor Paetznick; John H Rex; Luis Ostrosky-Zeichner
Journal:  Antimicrob Agents Chemother       Date:  2007-09-04       Impact factor: 5.191

2.  Anti-metabolic activity of caspofungin against Candida albicans and Candida parapsilosis biofilms.

Authors:  Christophe Cocuaud; Marie-Hélène Rodier; Gyslaine Daniault; Christine Imbert
Journal:  J Antimicrob Chemother       Date:  2005-07-22       Impact factor: 5.790

3.  Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins.

Authors:  D M Kuhn; T George; J Chandra; P K Mukherjee; M A Ghannoum
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

4.  Changes in cell wall synthesis and ultrastructure during paradoxical growth effect of caspofungin on four different Candida species.

Authors:  Fernando C Bizerra; Analy S A Melo; Eduardo Katchburian; Edna Freymüller; Anita H Straus; Hélio K Takahashi; Arnaldo L Colombo
Journal:  Antimicrob Agents Chemother       Date:  2010-11-08       Impact factor: 5.191

5.  Paradoxical effect of caspofungin: reduced activity against Candida albicans at high drug concentrations.

Authors:  David A Stevens; Marife Espiritu; Rachana Parmar
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

6.  The increased role of non-albicans species in candidaemia: results from a 3-year surveillance study.

Authors:  Thean Y Tan; Ai L Tan; Nancy W S Tee; Lily S Y Ng; Chloe W J Chee
Journal:  Mycoses       Date:  2010-11       Impact factor: 4.377

7.  In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance.

Authors:  M A Pfaller; L Boyken; R J Hollis; J Kroeger; S A Messer; S Tendolkar; D J Diekema
Journal:  J Clin Microbiol       Date:  2007-11-21       Impact factor: 5.948

8.  Biofilm formation and effect of caspofungin on biofilm structure of Candida species bloodstream isolates.

Authors:  J A G Ferreira; J H Carr; C E F Starling; M A de Resende; R M Donlan
Journal:  Antimicrob Agents Chemother       Date:  2009-06-22       Impact factor: 5.191

9.  Paradoxical growth effects of the echinocandins caspofungin and micafungin, but not of anidulafungin, on clinical isolates of Candida albicans and C. dubliniensis.

Authors:  M Fleischhacker; C Radecke; B Schulz; M Ruhnke
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-12-04       Impact factor: 3.267

10.  Epidemiological trends in nosocomial candidemia in intensive care.

Authors:  Matteo Bassetti; Elda Righi; Alessandro Costa; Roberta Fasce; Maria Pia Molinari; Raffaella Rosso; Franco Bobbio Pallavicini; Claudio Viscoli
Journal:  BMC Infect Dis       Date:  2006-02-10       Impact factor: 3.090
View more
  7 in total

1.  Cranberry-derived proanthocyanidins prevent formation of Candida albicans biofilms in artificial urine through biofilm- and adherence-specific mechanisms.

Authors:  Hallie S Rane; Stella M Bernardo; Amy B Howell; Samuel A Lee
Journal:  J Antimicrob Chemother       Date:  2013-10-10       Impact factor: 5.790

2.  In vitro analyses of ethanol activity against Candida albicans biofilms.

Authors:  Hallie S Rane; Stella M Bernardo; Carla J Walraven; Samuel A Lee
Journal:  Antimicrob Agents Chemother       Date:  2012-05-21       Impact factor: 5.191

3.  Species-specific and drug-specific differences in susceptibility of Candida biofilms to echinocandins: characterization of less common bloodstream isolates.

Authors:  Maria Simitsopoulou; Pavla Peshkova; Efthymia Tasina; Aspasia Katragkou; Daniela Kyrpitzi; Aristea Velegraki; Thomas J Walsh; Emmanuel Roilides
Journal:  Antimicrob Agents Chemother       Date:  2013-03-25       Impact factor: 5.191

Review 4.  Antifungal lock therapy.

Authors:  Carla J Walraven; Samuel A Lee
Journal:  Antimicrob Agents Chemother       Date:  2012-10-15       Impact factor: 5.191

5.  Quinacrine inhibits Candida albicans growth and filamentation at neutral pH.

Authors:  Vibhati V Kulkarny; Alba Chavez-Dozal; Hallie S Rane; Maximillian Jahng; Stella M Bernardo; Karlett J Parra; Samuel A Lee
Journal:  Antimicrob Agents Chemother       Date:  2014-10-06       Impact factor: 5.191

Review 6.  Antifungal lock therapy: an eternal promise or an effective alternative therapeutic approach?

Authors:  R Kovács; L Majoros
Journal:  Lett Appl Microbiol       Date:  2022-01-30       Impact factor: 2.813

Review 7.  The Role of Antifungals against Candida Biofilm in Catheter-Related Candidemia.

Authors:  Emilio Bouza; Jesús Guinea; María Guembe
Journal:  Antibiotics (Basel)       Date:  2014-12-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.